| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 16.417 | 47.481 | 83.192 | 45.054 | 147.694 | 13.008 |
| Total Income - EUR | - | - | - | - | 16.421 | 47.555 | 83.264 | 45.075 | 147.768 | 13.097 |
| Total Expenses - EUR | - | - | - | - | 14.751 | 43.784 | 82.836 | 49.563 | 150.607 | 17.408 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.670 | 3.771 | 428 | -4.488 | -2.839 | -4.311 |
| Net Profit/Loss - EUR | - | - | - | - | 1.177 | 2.878 | -183 | -4.939 | -4.287 | -4.442 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oviroxdana - Baţa S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 36.738 | 130.954 | 150.755 | 138.058 | 21.318 | 20.656 |
| Inventories | - | - | - | - | 33.041 | 130.569 | 125.157 | 114.084 | 13.242 | 12.184 |
| Receivables | - | - | - | - | 15 | 0 | 22.319 | 20.566 | 7.575 | 8.118 |
| Cash | - | - | - | - | 3.682 | 385 | 3.279 | 3.408 | 501 | 354 |
| Shareholders Funds | - | - | - | - | 1.219 | 4.074 | 3.801 | -1.126 | -5.411 | -9.823 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 35.518 | 126.880 | 146.955 | 139.184 | 26.729 | 30.479 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Oviroxdana - Baţa S.r.l.